Logo

BGI Extends Offer for Complete Genomics Until March 14

Mar 04, 2013 | staff reporter

NEW YORK (GenomeWeb News) – BGI said today that it has extended its cash tender offer for Complete Genomics until 11:59 PM EDT, March 14.

The deadline for the approximately $118 million deal, which has been extended numerous times, previously had been midnight EST March 1. Last week BGI said that the Ministry of Commerce of the People's Republic of China had approved the deal but that it was still awaiting approval by China's State Administration of Foreign Exchange.

The depositary for the offer has indicated that as of the close of business on March 1, more than 30.7 million shares, or 87 percent, of Complete's stock had been validly tendered and not withdrawn, BGI said.

Filed under

Clinical Sequencing
Sequencing
Business News
tender offer
mergers & acquisitions
MGI Tech
BGI
Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.